Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression (Q64049358)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

main subject

Dense deposit disease.

0 references

mycophenolate mofetil

0 references

1 reference

Karsten Häffner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Stefan Michelfelder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Martin Pohl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

19 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1951-1959

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

Renal transplantation in patients with dense deposit disease: morphological characteristics of recurrent disease and clinical outcome

8 March 2020

cites work

1 reference

12 December 2020

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

1 reference

12 December 2020

Eculizumab in a patient with dense-deposit disease

1 reference

12 December 2020

Causes of alternative pathway dysregulation in dense deposit disease

1 reference

12 December 2020

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation

1 reference

12 December 2020

A new screening test for C3 nephritis factor based on a stable cell bound convertase on sheep erythrocytes

1 reference

12 December 2020

Membranoproliferative glomerulonephritis--a new look at an old entity

1 reference

12 December 2020

Advances in apheresis therapy for glomerular diseases

1 reference

12 December 2020

Recurrent dense deposit disease after renal transplantation: an emerging role for complementary therapies

1 reference

12 December 2020

Toward a working definition of C3 glomerulopathy by immunofluorescence

1 reference

12 December 2020

Eculizumab for dense deposit disease and C3 glomerulonephritis

1 reference

12 December 2020

Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.

1 reference

12 December 2020

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

1 reference

12 December 2020

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

1 reference

12 December 2020

Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

1 reference

12 December 2020

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity

1 reference

12 December 2020

Eculizumab for the Treatment of Dense-Deposit Disease

1 reference

12 December 2020

C3 nephritic factor and hypocomplementaemia in a clinically healthy individual

1 reference

12 December 2020

New approaches to the treatment of dense deposit disease

1 reference

12 December 2020

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

1 reference

12 December 2020

Rituximab fails where eculizumab restores renal function in C3nef-related DDD

1 reference

12 December 2020

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Treatment options for C3 glomerulopathy

1 reference

12 December 2020

C3 nephritic factor associated with C3 glomerulopathy in children

1 reference

12 December 2020

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

1 reference

12 December 2020

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

1 reference

12 December 2020

Determining the population frequency of the CFHR3/CFHR1 deletion at 1q32.

1 reference

12 December 2020

Anti-complement therapy for glomerular diseases

1 reference

12 December 2020

Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange.

1 reference

12 December 2020

Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation

1 reference

12 December 2020

Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome

1 reference

12 December 2020

Clinical features and outcomes of 98 children and adults with dense deposit disease.

1 reference

12 December 2020

A simple height-independent equation for estimating glomerular filtration rate in children

1 reference

12 December 2020

Blockade of alternative complement pathway in dense deposit disease

1 reference

12 December 2020

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification

1 reference

12 December 2020

Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids

1 reference

12 December 2020

Mycophenolate mofetil treatment for primary glomerular diseases

1 reference

12 December 2020

FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene.

1 reference

12 December 2020

Mycophenolate mofetil in primary glomerulopathies.

1 reference

12 December 2020

A descriptive study of individuals with membranoproliferative glomerulonephritis.

1 reference

12 December 2020

10.1007/S00467-015-3111-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986912%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference